Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.745 USD | +0.29% | -5.43% | +332.84% |
01:52pm | RBC Starts Perspective Therapeutics With Outperform Rating, $3 Price Target | MT |
May. 09 | Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+332.84% | 1.02B | |
-5.77% | 182B | |
+2.03% | 111B | |
-3.58% | 68.48B | |
+1.22% | 49.69B | |
+7.94% | 44.46B | |
+2.33% | 40.67B | |
+23.64% | 31.22B | |
+0.58% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Isoray, Inc. Provides Sales Guidance for the First Quarter of Fiscal 2021